Ces annonces font suite aux conclusions de l’Agence européenne des médicaments (EMA) mercredi, confirmant “un lien possible” entre le vaccin anglo-suédois et des cas de thromboses très rares.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.